CVE Tools

CVE-2026-108796

ZKTeco BioTime Biometric Data Endpoint finger_data authorization

No known exploitation. EPSS puts it in the 12th percentile. Fixed in 9.5.6 Build 3623.

Published Updated Sources: CVE.org, NVD

What to do

Find your product and version, then upgrade to the build on the right.

  • ZKTeco BioTimeAffected: 9.5.6 Build 20260130.3206Upgrade to: not statedFixed builds9.5.6 Build 3623Stated by: CVE record

Versions as the sources state them. Full version matrix after sign-in

What it is

From the CVE record

A flaw has been found in ZKTeco BioTime 9.5.6 Build 20260130.3206. This affects an unknown part of the file /iclock/finger_data/ of the component Biometric Data Endpoint. Executing a manipulation of the argument emp_code can lead to authorization bypass. The attack can be launched remotely. Upgrading to version 9.5.6 Build 3623 is able to mitigate this issue. You should upgrade the affected component.

In plain language

No plain-language summary for this CVE yet.

Exploitation

Where each signal puts this CVE on the scale from published to confirmed exploited.

EPSS12th
CISA KEV

Not in the catalog. CISA has not confirmed exploitation.

Public exploits

No public exploit or proof of concept found in the sources we track.

EPSS

0.2% chance of exploitation activity in the next 30 days, which ranks it in the 12th percentile of scored CVEs.

Exploit Prediction Scoring System, FIRST.org. A probability, not a confirmation.

Lifecycle

7 events over 4 days, from the signal feeds we watch.

  1. Record updated
  2. Record updated
  3. Record updated
  4. Publishedweakness classified, att&ck mapped, record updated

Affected products

Technical detail

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

Scored 4.3 by NVD.

How it is reached

  • Attack Vector NetworkExploitable remotely over the network without any special conditions
  • Attack Complexity LowNo special conditions — the attack can be reliably reproduced
  • Privileges Required LowRequires basic user-level privileges
  • User Interaction NoneNo user interaction needed — fully automated exploitation

Scope

  • Scope UnchangedImpact is limited to the vulnerable component itself

Impact if exploited

  • Confidentiality LowSome restricted information is disclosed, but limited in scope
  • Integrity NoneNo integrity impact
  • Availability NoneNo availability impact

Weaknesses

ATT&CK techniques

Mapped from the weaknesses above (CWE to ATT&CK), not observed in attacks.

Sources

Watch the software you run.

My Stack ranks new CVEs for your products by real-world exploitation, so the next serious one reaches you without reading every advisory.

We'll flag the next CVE, public exploit or patch for BioTime, not every advisory.